Page last updated: 2024-10-24

chlorambucil and Aortic Arch Syndrome

chlorambucil has been researched along with Aortic Arch Syndrome in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WHITAKER, W1
BREWER, D1
FITZGERALD, M1
HEATH, D1
Rossor, E1

Other Studies

2 other studies available for chlorambucil and Aortic Arch Syndrome

ArticleYear
CLINICAL PATHOLOGIC CONFERENCE. TAKAYASHU'S SYNDROME; HODGKIN'S DISEASE.
    American heart journal, 1964, Volume: 68

    Topics: Aortic Arch Syndromes; Chlorambucil; Drug Therapy; Hodgkin Disease; Humans; Pathology; Prednisone; T

1964
Takayasu's arteritis as a differential diagnosis of systemic juvenile chronic arthritis.
    Archives of disease in childhood, 1979, Volume: 54, Issue:10

    Topics: Aortic Arch Syndromes; Aortography; Arthritis, Juvenile; Child; Chlorambucil; Diagnosis, Differentia

1979